BDC Capital provides mezz funding to venture-backed Nicoya
May 14, 2019 / Source: The PE Hub Network
BDC Capital has provided undisclosed mezzanine financing to Nicoya Lifesciences Inc, a Kitchener, Ontario-based nanotechnology company.
The funding is part of a $7.7 million investment in Nicoya that is also backed by FedDev Ontario.
BDC invested through its Growth & Transition Capital group. The transaction was led by Director Mark Lunick.
The funds raised will allow Nicoya to develop and market a new version of its flagship product, OpenSPR, a biosensor platform that supports biotechnology and pharmaceutical research applications, and meet demand.
Last year, Nicoya closed a $2 million financing led by Ripple Ventures and Golden Triangle Angel Network. BDC also invested in the round.
Read the full article here.